Pancreatic endocrine tumors: Epidemiology, pathology, pathophysiology, and diagnosis

C. Shibata; Y. Funayama; I. Sasaki

doi:10.1007/978-3-540-28656-1_68

Pancreatic endocrine tumors: Epidemiology, pathology, pathophysiology, and diagnosis

C. Shibata, Y. Funayama, I. Sasaki

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Citation (Scopus)

Abstract

Pancreatic endocrine tumors (PETs) occupy only 2-3% of pancreatic neoplasms and can be divided into two classes depending on whether or not the tumor secretes peptides (functioning or nonfunctioning). Patients with a functioning tumor, in particular, require specific examinations including hormonal tests. Nonfunctioning tumors comprise 30-40% of PETs [1, 2] and are believed to be the most common class of PETs. In this chapter, we overview the history, epidemiology and pathology, clinical manifestations, diagnosis, and treatment of functioning [insulinoma, gastrinoma, glucagonoma, vasoactive intestinal peptide (VIP)-oma, and somatostatinoma) and nonfunctioning PETs

Original language	English
Title of host publication	Diseases of the Pancreas
Subtitle of host publication	Current Surgical Therapy
Publisher	Springer Berlin Heidelberg
Pages	707-713
Number of pages	7
ISBN (Print)	9783540286554
DOIs	https://doi.org/10.1007/978-3-540-28656-1_68
Publication status	Published - 2008
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-540-28656-1_68

Cite this

@inbook{7b51a7a9df9d4098957c17377267cda4,

title = "Pancreatic endocrine tumors: Epidemiology, pathology, pathophysiology, and diagnosis",

abstract = "Pancreatic endocrine tumors (PETs) occupy only 2-3% of pancreatic neoplasms and can be divided into two classes depending on whether or not the tumor secretes peptides (functioning or nonfunctioning). Patients with a functioning tumor, in particular, require specific examinations including hormonal tests. Nonfunctioning tumors comprise 30-40% of PETs [1, 2] and are believed to be the most common class of PETs. In this chapter, we overview the history, epidemiology and pathology, clinical manifestations, diagnosis, and treatment of functioning [insulinoma, gastrinoma, glucagonoma, vasoactive intestinal peptide (VIP)-oma, and somatostatinoma) and nonfunctioning PETs",

author = "C. Shibata and Y. Funayama and I. Sasaki",

year = "2008",

doi = "10.1007/978-3-540-28656-1_68",

language = "English",

isbn = "9783540286554",

pages = "707--713",

booktitle = "Diseases of the Pancreas",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Pancreatic endocrine tumors

T2 - Epidemiology, pathology, pathophysiology, and diagnosis

AU - Shibata, C.

AU - Funayama, Y.

AU - Sasaki, I.

PY - 2008

Y1 - 2008

N2 - Pancreatic endocrine tumors (PETs) occupy only 2-3% of pancreatic neoplasms and can be divided into two classes depending on whether or not the tumor secretes peptides (functioning or nonfunctioning). Patients with a functioning tumor, in particular, require specific examinations including hormonal tests. Nonfunctioning tumors comprise 30-40% of PETs [1, 2] and are believed to be the most common class of PETs. In this chapter, we overview the history, epidemiology and pathology, clinical manifestations, diagnosis, and treatment of functioning [insulinoma, gastrinoma, glucagonoma, vasoactive intestinal peptide (VIP)-oma, and somatostatinoma) and nonfunctioning PETs

AB - Pancreatic endocrine tumors (PETs) occupy only 2-3% of pancreatic neoplasms and can be divided into two classes depending on whether or not the tumor secretes peptides (functioning or nonfunctioning). Patients with a functioning tumor, in particular, require specific examinations including hormonal tests. Nonfunctioning tumors comprise 30-40% of PETs [1, 2] and are believed to be the most common class of PETs. In this chapter, we overview the history, epidemiology and pathology, clinical manifestations, diagnosis, and treatment of functioning [insulinoma, gastrinoma, glucagonoma, vasoactive intestinal peptide (VIP)-oma, and somatostatinoma) and nonfunctioning PETs

UR - http://www.scopus.com/inward/record.url?scp=79956219803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956219803&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-28656-1_68

DO - 10.1007/978-3-540-28656-1_68

M3 - Chapter

AN - SCOPUS:79956219803

SN - 9783540286554

SP - 707

EP - 713

BT - Diseases of the Pancreas

PB - Springer Berlin Heidelberg

ER -

Pancreatic endocrine tumors: Epidemiology, pathology, pathophysiology, and diagnosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this